Medical education review — 10 November 2026. Not a substitute for individualized diagnosis, prescribing advice or local guidance.
Overview
Thyroid hormone replacement treats hypothyroidism, whereas thionamides, radioactive iodine, surgery and symptom control are used for selected hyperthyroid conditions. Assessment begins with thyroid function tests interpreted in the clinical context; pregnancy requires a dedicated approach [1, 2, 3].
Thyroid hormone pharmacology
Levothyroxine (T4) is first-line replacement for primary hypothyroidism because it is converted peripherally to triiodothyronine (T3) and has a long half-life of approximately a week in euthyroid adults. T3 binds nuclear thyroid hormone receptors (TRα/TRβ), altering transcription of genes involved in metabolism, growth and cardiac activity. Liothyronine has a shorter half-life and is not routine first-line replacement. Reverse T3 is a largely inactive metabolite, not a standard treatment target [1, 2].
Administration and monitoring
Levothyroxine should be taken consistently, ideally on an empty stomach as instructed for the formulation, and separated from calcium, iron and certain antacids because they impair absorption. Dose needs may change with age, body weight, pregnancy, gastrointestinal disease and interacting medicines. TSH usually guides primary hypothyroidism treatment, reassessed after approximately 6–8 weeks of dose changes; in central hypothyroidism, free T4 rather than TSH is the primary biochemical guide [1].
Antithyroid drugs and mechanisms
- Methimazole/carbimazole: inhibit thyroid peroxidase-mediated iodide organification and coupling; carbimazole is a prodrug of methimazole.
- Propylthiouracil (PTU): inhibits thyroid peroxidase and additionally inhibits peripheral T4-to-T3 conversion at higher concentrations.
- Iodide: in large pharmacologic doses transiently inhibits hormone release (and organification) and may be used before surgery or in thyroid storm as part of specialist care.
- Beta blockers: improve adrenergic symptoms but do not treat the underlying synthesis defect; propranolol at higher doses can reduce T4-to-T3 conversion.
- Radioactive iodine and thyroidectomy: definitive treatments for selected etiologies of hyperthyroidism.
Safety and adverse reactions
Thionamides may cause rash, arthralgia, agranulocytosis and liver injury. Explain that fever or sore throat while taking a thionamide requires stopping it and urgent evaluation with blood counts; jaundice or dark urine warrants urgent hepatic review. PTU has greater concern for severe hepatotoxicity, while methimazole has dose-related congenital-malformation concerns in early pregnancy. Pregnancy management is individualized; radioactive iodine is contraindicated during pregnancy [2, 3].
Pregnancy updates
Pregnancy raises thyroid hormone requirements in many levothyroxine-treated patients and necessitates prompt thyroid testing and dose reassessment. The 2026 American Thyroid Association pregnancy guidance refines treatment thresholds and monitoring for subclinical disease; avoid using outdated anti-TPO-positive status alone as an automatic treatment trigger. For Graves disease, antithyroid drug selection and dose should minimize maternal and fetal harms and be overseen by a specialist [3].
Central hypothyroidism, pregnancy and thyroid storm
Central hypothyroidism requires a different monitoring strategy. Pituitary disease can produce low free T4 with a low or apparently normal TSH. Use free T4 to guide replacement. Assess adrenal function first, because starting levothyroxine in untreated central adrenal insufficiency can precipitate adrenal crisis. [4]
Methimazole is generally preferred for Graves disease outside pregnancy. Fever or a severe sore throat during thionamide treatment warrants stopping the drug and urgently obtaining a differential blood count to assess for agranulocytosis. Jaundice or dark urine requires prompt evaluation for liver injury. PTU carries a particular risk of severe hepatic injury. When treatment is required in early pregnancy, PTU is generally preferred. The 2026 ATA guideline advises individualising the choice if treatment continues beyond 16 weeks. [5, 3]
Fever, marked tachycardia and altered mental status in a thyrotoxic patient warrant emergency assessment. In storm caused by excess synthesis, give a thionamide first and wait at least one hour before iodide. The delay allows synthesis blockade before an iodine load is given. Hospital treatment also addresses the precipitating illness and may include glucocorticoids, carefully selected heart-rate control, cooling and circulatory support. [6]
Clinical pearls
Thionamides inhibit new hormone synthesis; they do not rapidly clear already synthesized stores. Differentiate Graves disease from destructive thyroiditis, in which antithyroid drugs usually have no role [2].
References
- Brunton LL, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. McGraw Hill; 2023.
- American Thyroid Association. Hyperthyroidism (overactive). Clinical information. Available from: https://www.thyroid.org/hyperthyroidism/
- American Thyroid Association. 2026 guidelines for thyroid disease in preconception, pregnancy, and postpartum. doi:10.1177/10507256261445624. Available from: https://doi.org/10.1177/10507256261445624
- Endocrine Society. Hormonal replacement in hypopituitarism in adults. Clinical practice guideline. 2016. [cited 2026 Nov 10]. View source.
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–1421. [cited 2026 Nov 10]. View source.
- Endotext. Thyroid storm. Table 3. Treatment of thyroid storm. [cited 2026 Nov 10]. View source.
Medical & AI Disclaimer
The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.
We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.